Analysis of socio-demographic and clinical-morphological characteristics of recurrent and metastatic cervical cancer
- Authors: Orlova R.V.1,2, Gorkina Y.R.1,2, Protasova A.E.1,3,4, Molchanov S.V.2, Krotov M.Y.2
-
Affiliations:
- Saint Petersburg State University
- City Clinical Oncology Dispensary
- Almazov National Medical Research Center
- AVA-PETER LLC
- Issue: Vol 32, No 6 (2025)
- Pages: 220-226
- Section: Oncology
- URL: https://bakhtiniada.ru/2073-4034/article/view/350664
- DOI: https://doi.org/10.18565/pharmateca.2025.6.220-226
- ID: 350664
Cite item
Open Access
Access granted
Subscription Access
Abstract
Background: Cervical cancer (CC) remains one of the most common malignant tumors of the female reproductive system, especially in developing countries, where the disease is often diagnosed at late stages.
Objective: Analysis of the socio-demographic and clinical-morphological characteristics of patients with recurrent and metastatic cervical cancer.
Materials and methods: This study analyzed the sociodemographic, clinical, morphological, and reproductive characteristics of 756 patients with recurrent and metastatic cervical cancer treated at the St. Petersburg City Clinical Oncology Dispensary from 2020 to 2024. The study focused on 216 randomly selected case histories.
Results: The mean patient age was 48 years, with the majority (76.72%) over 40 years of age. Women with established reproductive function (77.5% had two or more pregnancies) and a history of abortions (63.75%) were predominant. Most patients (67.5%) were unemployed, and among those who were employed, highly skilled workers predominated (17.5%). A significant factor in late diagnosis was the lack of regular gynecological examinations: 41.25% of patients had no record of their last gynecological visit, and 23.75% had not seen a doctor for more than 1–5 years. In 48.75% of cases, the disease was diagnosed at stage IIIB, and the predominant histological type was squamous cell carcinoma (88.75%).
Conclusion: The study identified the need to strengthen screening programs, including HPV testing and cytological examination, as well as to increase women’s awareness of the importance of regular gynecological examinations. These measures can facilitate early diagnosis and reduce the incidence of advanced forms of cervical cancer.
Full Text
##article.viewOnOriginalSite##About the authors
Rashida V. Orlova
Saint Petersburg State University; City Clinical Oncology Dispensary
Email: yana_gorkina@mail.ru
ORCID iD: 0000-0002-9368-5517
SPIN-code: 9932-6170
Dr. Sci. (Med.), Professor, Honored Doctor of the Russian Federation, Head of the Oncology Department, Medical Institute; Chief Specialist in Clinical Oncology and Rehabilitation
Russian Federation, Saint Petersburg; Saint PetersburgYana R. Gorkina
Saint Petersburg State University; City Clinical Oncology Dispensary
Author for correspondence.
Email: yana_gorkina@mail.ru
ORCID iD: 0009-0006-9670-744X
SPIN-code: 4763-1626
ResearcherId: MXL-7201-2025
Postgraduate Student, Oncology Department, Medical Institute; Oncologist, Day Hospital for Surgical Treatment No. 18
Russian Federation, Saint Petersburg; Saint PetersburgAnna E. Protasova
Saint Petersburg State University; Almazov National Medical Research Center; AVA-PETER LLC
Email: yana_gorkina@mail.ru
ORCID iD: 0000-0001-7930-8048
Dr. Sci. (Med.), Professor, Department of Oncology, Medical Institute; Professor, Department of Obstetrics and Gynecology; Oncogynecologist
Russian Federation, Saint Petersburg; Saint Petersburg; Saint PetersburgSergey V. Molchanov
City Clinical Oncology Dispensary
Email: yana_gorkina@mail.ru
ORCID iD: 0000-0002-0522-1772
SPIN-code: 2719-3289
Cand. Sci. (Med.), Head of the Oncogynecology Department No. 3
Russian Federation, Saint PetersburgMikhail Yu. Krotov
City Clinical Oncology Dispensary
Email: yana_gorkina@mail.ru
Methodologist, Head of the Organizational and Methodological Department
Russian Federation, Saint PetersburgReferences
- World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem: WHO [Электронный ресурс]. Geneva: World Health Organization, 2020. doi: 10.37669/9789240014107 URL: https://www.who.int/publications/i/item/9789240014107
- The Surveillance, Epidemiology, and End Results (SEER) Program. Cancer Stat Facts: Cervical Cancer [Electronic resource]. National Cancer Institute. 2024. URL: https://seer.cancer.gov/statfacts/html/cervix.html
- Злокачественные новообразования в России в 2023 году (заболеваемость и смертность). Под ред. А.Д. Каприна и др. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024. 276 с. илл. [Malignant neoplasms in Russia in 2023 (incidence and mortality). Ed. by A.D. Kaprin et al. Moscow: P.A. Herzen Moscow Oncology Research Institute – branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, 2024. 276 p. ill. (In Russ.)].
- Dahiya K., Dhall G.I., Duhan N. Clinicopathological study of cervical carcinoma in a tertiary care hospital. J Cancer Res Ther. 2016;12(2):123–127.
- Chopra S., Gupta M., Mathew A., Mahantshetty U. Late-stage cervical cancer: A retrospective analysis from a tertiary care center in India. International J GynecolCancer. 2019;29(5):987–993. doi: 10.1136/ijgc-2019-000240
- Cetina-Pérez L., López-Camarillo C., Pérez-Cárdenas E. Socioeconomic disparities and survival outcomes in cervical cancer: A population-based study. Cancer Epidemiol. 2024;68:101–108. doi: 10.1016/j.canep.2023.102094
- Dunyo P., Effah K., Adanu R. Factors associated with late diagnosis of cervical cancer in Ghana: A retrospective study. BMC Women’s Health. 2018;18(1):87–94. doi: 10.1186/s12905-018-0583-6
- Mwaka A.D., Orach C.G., Were E.M. Awareness of cervical cancer risk factors and symptoms among women in a developing country: A cross-sectional study. BMC Cancer. 2016;16(1):335–342. doi: 10.1186/s12885-016-2369-1
- Wassie M., Fentie B., Abebe T. Prevalence and predictors of late-stage cervical cancer presentation in Ethiopia: A multicenter study. PLOS ONE. 2021;16(4):e0249256. doi: 10.1371/journal.pone.0249256
- Gyenwali D., Khanal G., Tiwari P. Delays in diagnosis and treatment of cervical cancer in Nepal: A qualitative study. Asian Pacific J Cancer Prevent. 2013;14(10):5903–5908.
- Рак шейки матки: клинические рекомендации. Под ред. А.Д. Каприна. М.: ГЭОТАР-Медиа, 2023. 120 с. [Kaprin A.D. (ed.) Cervical cancer: clinical guidelines. Moscow: GEOTAR-Media, 2023. 120 p. (In Russ.)].
Supplementary files
